The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EKSO | -68.48% | -93.18% | -41.54% | -100% |
| S&P | +14.5% | +93.32% | +14.09% | +263% |
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.06M | -58.4% |
| Gross Profit | $0.82M | -68.9% |
| Gross Margin | 39.82% | -13.5% |
| Market Cap | $7.90M | -58.6% |
| Market Cap / Employee | $0.13M | 0.0% |
| Employees | 61 | -12.9% |
| Net Income | -$2.71M | -12.1% |
| EBITDA | -$3.60M | -85.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.24M | -10.9% |
| Accounts Receivable | $4.53M | -30.5% |
| Inventory | 5.4 | 9.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $3.69M | -26.3% |
| Short Term Debt | $1.70M | 1.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -44.21% | -3.5% |
| Return On Invested Capital | -85.87% | 17.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.48M | -30.5% |
| Operating Free Cash Flow | -$3.44M | -29.0% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.72 | 1.07 | 0.90 | 0.49 | -64.13% |
| Price to Sales | 1.33 | 0.84 | 0.58 | 0.49 | -53.76% |
| Price to Tangible Book Value | 39.15 | 20.59 | 17.44 | 0.78 | -97.61% |
| Enterprise Value to EBITDA | -9.68 | -7.93 | -2.55 | -2.03 | -80.31% |
| Return on Equity | -73.9% | -89.5% | -80.7% | -96.4% | 15.91% |
| Total Debt | $6.35M | $5.98M | $5.62M | $5.39M | -19.43% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
